Evidence map›Paper›PMID 39991639›Full record

ArticleTelemedicine reports2025

Pharmacist Expectations of Telepharmacy Services in Community Pharmacies in Indonesia.

Imam Fathorrahman, Umi Athijah, Andi Hermansyah, Abdul Rahem

Abstract readCase Reports
In one paragraph

Article in Telemedicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Imam FathorrahmanDoctoral Programme Student, Faculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.
Umi AthijahFaculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.
Andi HermansyahFaculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.
Abdul RahemFaculty of Pharmacy, Universitas Airlangga, Surabaya, Indonesia.ORCID https://orcid.org/0000-0002-5264-4823

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The introduction of new digital-based services such as telehealth, telemedicine, telepharmacy, and other digital health services is expected to continue to evolve, both for the benefit of science. Increasing pharmacists' roles in pharmaceutical services is critical and strategic in accelerating and recovering public health in the digital era because pharmacists can ensure the availability of appropriate, safe, and effective drugs while also monitoring the rational use of drugs to achieve therapeutic goals. Objective: This study will look at patient and pharmacist preferences for telepharmacy. This study examines pharmacist preferences for telepharmacy. Material and Methods: This study includes a sample of 457 Indonesian pharmacists. This cross-sectional study was carried out on pharmacists throughout Indonesia in December 2023. The tool utilized was a questionnaire with an online data collection mechanism. The online questionnaire was designed to capture pharmacists' expectations for existing telepharmacy service practices using the inclusion criteria listed below. This study followed the standards of the Declaration of Helsinki, and electronic informed participant consent was acquired. The Medical Ethics Committee of the Faculty of Pharmacy, Universitas Airlangga, approved the study. Conclusion: According to the study's findings, the vast majority of pharmacists support the extensive and integrated usage of telepharmacy. This is backed by the belief that pharmaceutical services will be a lucrative possibility in the future. Overall, the data show that patients and pharmacists are willing to adopt and incorporate telepharmacy services.

Indexed as

digital healthtelehealthtelemedicinetelepharmacy

Identifiers

PMID39991639
PMCPMC11839528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.